News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
827,387 Results
Type
Article (76191)
Company Profile (645)
Press Release (750551)
Multimedia
Podcasts (127)
Webinars (14)
Section
Business (230960)
Career Advice (3763)
Deals (39519)
Drug Delivery (129)
Drug Development (90079)
Employer Resources (198)
FDA (17971)
Job Trends (17206)
News (392590)
Policy (39078)
Tag
Academia (2999)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56509)
ALS (99)
Alzheimer's disease (1502)
Antibody-drug conjugate (ADC) (158)
Approvals (17933)
Artificial intelligence (303)
Autoimmune disease (29)
Automation (16)
Bankruptcy (404)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (441)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (302)
Cancer (2444)
Cardiovascular disease (206)
Career advice (3208)
Career pathing (34)
CAR-T (174)
Cell therapy (484)
Cervical cancer (21)
Clinical research (72768)
Collaboration (916)
Company closure (1)
Compensation (569)
Complete response letters (30)
COVID-19 (2867)
CRISPR (48)
C-suite (267)
Cystic fibrosis (107)
Data (2286)
Decentralized trials (2)
Denatured (45)
Depression (55)
Diabetes (299)
Diagnostics (6917)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (132)
Drug pricing (127)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (96070)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (129541)
Executive appointments (781)
FDA (19318)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (813)
Gene editing (120)
Generative AI (28)
Gene therapy (357)
GLP-1 (854)
Government (5116)
Grass and pollen (6)
Guidances (79)
Healthcare (20874)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (148)
Indications (30)
Infectious disease (3027)
Inflammatory bowel disease (156)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (101)
Interviews (735)
IPO (17783)
IRA (51)
Job creations (5059)
Job search strategy (2623)
Kidney cancer (11)
Labor market (42)
Layoffs (557)
Leadership (24)
Legal (9981)
Liver cancer (82)
Lung cancer (345)
Lymphoma (159)
Machine learning (7)
Management (65)
Manufacturing (346)
MASH (76)
Medical device (14621)
Medtech (14626)
Mergers & acquisitions (22285)
Metabolic disorders (793)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (114)
Neuropsychiatric disorders (34)
Neuroscience (2106)
NextGen: Class of 2025 (7640)
Non-profit (5081)
Now hiring (40)
Obesity (427)
Opinion (275)
Ovarian cancer (79)
Pain (101)
Pancreatic cancer (88)
Parkinson's disease (160)
Partnered (22)
Patents (253)
Patient recruitment (116)
Peanut (51)
People (64788)
Pharmaceutical (133)
Pharmacy benefit managers (21)
Phase I (22520)
Phase II (31694)
Phase III (23872)
Pipeline (1277)
Policy (173)
Postmarket research (3346)
Preclinical (9974)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (429)
Real estate (7241)
Recruiting (75)
Regulatory (26311)
Reports (57)
Research institute (2655)
Resumes & cover letters (586)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (143)
Series B (92)
Service/supplier (27)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4239)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (47)
The Weekly (80)
Vaccines (814)
Venture capitalists (44)
Weight loss (305)
Women's health (40)
Worklife (20)
Date
Today (184)
Last 7 days (889)
Last 30 days (2855)
Last 365 days (35374)
2025 (11794)
2024 (37905)
2023 (42567)
2022 (53927)
2021 (58723)
2020 (57665)
2019 (51306)
2018 (39093)
2017 (36900)
2016 (37900)
2015 (43972)
2014 (38916)
2013 (35113)
2012 (37133)
2011 (37290)
2010 (37082)
Location
Africa (1199)
Alabama (60)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (48870)
Australia (8409)
California (6490)
Canada (2075)
China (566)
Colorado (284)
Connecticut (302)
Delaware (161)
Europe (110668)
Florida (947)
Georgia (221)
Hawaii (1)
Idaho (63)
Illinois (619)
India (30)
Indiana (336)
Iowa (12)
Japan (171)
Kansas (111)
Kentucky (28)
Louisiana (14)
Maine (70)
Maryland (972)
Massachusetts (4976)
Michigan (247)
Minnesota (423)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (66)
New Hampshire (69)
New Jersey (1835)
New Mexico (31)
New York (1840)
North Carolina (1128)
North Dakota (9)
Northern California (2777)
Ohio (220)
Oklahoma (15)
Oregon (46)
Pennsylvania (1429)
Puerto Rico (13)
Rhode Island (36)
South America (1578)
South Carolina (24)
South Dakota (1)
Southern California (2409)
Tennessee (105)
Texas (966)
United States (24882)
Utah (194)
Virginia (170)
Washington D.C. (71)
Washington State (602)
West Virginia (3)
Wisconsin (68)
827,387 Results for "cura pharmaceutical co inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
April 29, 2025
·
1 min read
Press Releases
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results
March 28, 2025
·
10 min read
Xediton Pharmaceuticals Inc. To Present at The 2024 Bloom Burton & Co. Healthcare Investor Conference
Xediton Pharmaceuticals Inc., a leading Canadian specialty pharmaceutical company, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor
April 9, 2024
·
2 min read
Biotech Bay
NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
NovaBay® Pharmaceuticals, Inc. and Eyenovia, Inc. have commenced activities under a previously announced co-promotion agreement.
July 1, 2024
·
8 min read
Press Releases
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
May 1, 2025
·
7 min read
Press Releases
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast
March 13, 2025
·
1 min read
Press Releases
Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025
March 4, 2025
·
4 min read
Press Releases
Co-Diagnostics, Inc. to Exhibit at BioUtah’s 2025 Life Sciences Day on the Hill
January 31, 2025
·
2 min read
Press Releases
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 12, 2025
·
6 min read
Policy
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. announced that the Company has completed its first U.S. Food and Drug Administration application for 510 clearance for the Co-Dx™ PCR Pro™ instrument, and the Co-Dx PCR COVID-19 Test for over-the-counter use.
June 14, 2024
·
4 min read
1 of 82,739
Next
